High-fat diets and cardiovascular disease: Are nutritional supplements useful?

Journal of the American College of Cardiology

Volumn 41, Issue 10, 2003, Pages 1750-1752

  Freedman, Jane E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ESTROGEN; FLAVONOID; NITRIC OXIDE; POLYPHENOL DERIVATIVE; PYRAN DERIVATIVE; SATURATED FATTY ACID; THROMBOCYTE SLOWING FACTOR; VASODILATOR AGENT; VITAMIN;

ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL REACTIVITY; BODY MASS; BRACHIAL ARTERY; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; DISEASE COURSE; DRUG TARGETING; ENZYME REGULATION; ESTROGEN THERAPY; FOOD; FRUIT JUICE; FRUIT VEGETABLE; GENDER; GRAPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID DIET; METABOLISM; NOTE; NUTRIENT; NUTRITIONAL SUPPORT; OBESITY; PATIENT EDUCATION; PHYTONUTRIENT; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SMOKING; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VASODILATATION; WINE;

EID: 0038239549     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00303-6     Document Type: Editorial

References (25)

1. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002;40:441-7.
2. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
3. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-42.
4. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
5. St. Leger A, Cochrane A, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;124:1017-20.
6. D'Odorico A, Martines D, Kiechl S, et al. High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis: results from the Bruneck study. Atherosclerosis 2000;153:231-9.
7. de Gaetano G. Low-dose aspitin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001;357:89-95.
8. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154-60.
9. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-34.
10. Willerson J, Golino P, Eidt J, Campbell W, Buja L. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 1989;80:198-205.
11. Freedman JE, Parker C 3rd, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001;103:2792-8.
12. Stein J, Keevil J, Wiebe D, Aeschlimann S, Folts J. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999;100:1050-5.
13. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000;130:53-6.
14. Freedman JE, Keaney JF Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001;131:374S-7S.
15. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
16. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
17. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8.
18. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 2002;106:640-2.
19. Keaney JF Jr., Gaziano JM, Xu A, et al. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994;93:844-51.
20. Gerhard M, Walsh BW, Tawakol A, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasoditation in post-menopausal women. Circulation 1998;98:1158-63.
21. Plotnick GD, Corretti MC, Vogel RA, Hesslink R Jr., Wise JA. Effect of supplemental phytonutrients on impairment of flow-mediated brachial artery vasoactivity after a single high-fat meal. J Am Coll Cardiol 2003;41:1744-9.
22. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-92.
23. Freedman JE, Farhat J, Loscalzo J, Keaney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996;94:2434-40.
24. Ferriola P, Cody V, Middleton E. Protein kinase C inhibition by plant flavonoids. Biochem Pharmacol 1988;38:1617-24.
25. Kooy M, Akkerman W, Van Asbeck S, Borghuis L, Van Prooijen H. UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Br J Haematol 1992;83:253-8.